Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Refractory Gout With Adrenocorticotropic Hormone or Methylprednisolone

NCT04808856 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.

NCT NCT04808856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04808856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Refractory Gout With Adrenocorticotropic Hormone or Methylprednisolone
Lead sponsor
Shanghai 10th People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2021
Completion date
April 1, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gout